Search for: "KV Pharmaceutical Company"
Results 61 - 67
of 67
Sort by Relevance
|
Sort by Date
2 Aug 2008, 12:54 am
– Technological Innovation and Intellectual Property), IP and start-ups: (Technological Innovation and Intellectual Property), Innovators: Make sure your company owns the fruits of your open innovation projects: (IP Asset Maximizer Blog), It’s all about the numbers: SuperCrunchers of patent data will gain competitive advantage: (IP Asset Maximizer Blog) Events 4-9 August: Dept Science & Technology indigenous knowledge systems expo and workshop… [read post]
31 Jul 2008, 9:44 pm
According to the company's web site: KV Pharmaceutical, with headquarters in St. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop –… [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real story:… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
6 Aug 2007, 4:37 am
KV Pharmaceutical Company, et al. (07/23/2007): multiple suits filed by plaintiffs in various jurisdictions asserting the defendants' filed ANDAs infringe their patents; cases consolidated in Missouri; appeal of grant of summary judgment finding the patents invalid and unenforceable (affirmed-in-part, vacated-in-part, and remanded); discussion of two patents related to a composition used to treat angina, hypertension, and congestive heart failure (U.S. [read post]
29 Oct 2006, 7:43 pm
Harper KV Pharmaceutical Company recently filed a citizen petition asking the FDA to relist U.S. [read post]
